share_log

Arcutis Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Burnett Patrick

Arcutis Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Burnett Patrick

Arcutis Biotherapeutics | 4:持股变动声明-高管 Burnett Patrick
美股sec公告 ·  05/03 16:29
Moomoo AI 已提取核心信息
Patrick Burnett, associated with Arcutis Biotherapeutics, Inc. [ARQT], completed a sale of 9,555 shares of common stock on May 2, 2024. The transaction was executed in the open market at a price of $8.7378 per share, resulting in a total sale value of approximately $83,489.68. Following the sale, Burnett's direct holdings in the company amount to 259,745 shares of common stock.
Patrick Burnett, associated with Arcutis Biotherapeutics, Inc. [ARQT], completed a sale of 9,555 shares of common stock on May 2, 2024. The transaction was executed in the open market at a price of $8.7378 per share, resulting in a total sale value of approximately $83,489.68. Following the sale, Burnett's direct holdings in the company amount to 259,745 shares of common stock.
与Arcutis Biotherapeutics, Inc. [ARQT] 相关的帕特里克·伯内特于2024年5月2日完成了9,555股普通股的出售。该交易在公开市场上以每股8.7378美元的价格执行,总销售价值约为83,489.68美元。出售后,伯内特在该公司的直接持有量为259,745股普通股。
与Arcutis Biotherapeutics, Inc. [ARQT] 相关的帕特里克·伯内特于2024年5月2日完成了9,555股普通股的出售。该交易在公开市场上以每股8.7378美元的价格执行,总销售价值约为83,489.68美元。出售后,伯内特在该公司的直接持有量为259,745股普通股。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息